Monday, April 19, 2021 1:43:42 PM
Folks, Biotech stock GLSI ran from $3 through $158 in a single day. I think SBFM is next.
COVID-19 Drug/Capsules/Pills Plus Cancer Drug are coming!! SBFM might have the potential to save millions of lives around the globe.
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment, 2021-04-19..Just amazing!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-favorable-mtd-120000152.html
SBFM recently submitted an application to UP-List to the OTCQB. Next step is listing at NASDAQ!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-completes-application-uplist-130000059.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a, the Company's Flagship Anticancer Compound Until 2033-Just Beautiful!
https://finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-130000340.html
SBFM has a number of shares outstanding only 465.005 million including restricted shares of 60.01 Million. With such a low OS in OTC, PPS @ $2..$4..$6..$8..$10++??, anything is possible.
https://www.otcmarkets.com/stock/SBFM/security
The fools who shorted SBFM shares will pay big time. Total Shorted Volume is 21.77 Million with an average shorted volume of 1.09 Million. Huge Short Squeeze is imminent. Shorts are gonna be scrambling, weeping and biting their nails.
https://marketwirenews.com/stock/sbfm/short/
Let's go SBFM to $5++ and NASDAQ !!
SHARE VALUATION:
As per MNP (one of the largest public accountancy firms in Canada), an estimated Fair Market Value of issued and outstanding shares of SBFM as at March 31, 2017 was in the range of $977.0 million to $1,133.0 million.
https://finance.yahoo.com/news/sunshine-biopharma-releases-results-independent-130000009.html
So, Estimated PPS of SBFM (in 2017) = $1,100 million/465.005 million = $2.36 (without recent developments)
Presently, PPS of most COVID-19 stocks are between $4 through $160.
Folks! act prudently and be financially solvent at this very very difficult time.
RECENT DEVELOPMENTS:
Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-reaches-2-000-130000199.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033, 2021-03-11
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-140000158.html
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-recently-ordered-140000929.html
Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
https://ca.finance.yahoo.com/news/sunshine-biopharma-launches-ecommerce-store-141400955.html
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds, Feb. 4, 2021
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-exclusive-license-130000848.html
Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-fourth-tranche-133000911.html
Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK, Dec. 22, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000305.html
Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers, Dec. 8, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-orders-batch-adva-130000761.html
Sunshine Biopharma Paid Off Convertible Notes in Cash Preventing New Shares From Hitting the Market, December 3, 2020..Just Beautiful!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-pays-off-convertible-130000473.html
Sunshine Biopharma Signed an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound....This is a HUGE NEWS!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-agreement-montreal-130000919.html
https://wallstreetwindow.com/2020/10/shares-of-sunshine-biopharma-inc-otcmkts-sbfm-rise-today-on-covid-drug-news-tim-bellamy-10-19-2020/
Recent SBFM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/20/2024 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/16/2024 09:00:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:09 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/11/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM